ElevateBio Executive and Leadership Team

Christopher Murphy, the Chief Executive Officer at ElevateBio, directs the overarching corporate strategy and operational framework. Murphy architects the company's expansion through strategic alliances and the development of its cell and gene therapy portfolio. Overseeing the integration of innovative scientific discoveries with operational execution, the Chief Executive Officer ensures alignment with ElevateBio's mission to create transformative treatments. This leadership role involves guiding the company's financial health and market positioning, driving sustainable growth and long-term value creation. By fostering a culture of scientific rigor and operational excellence, Christopher Murphy solidifies ElevateBio's standing as a leader in the biotechnology sector, impacting patient outcomes through advanced therapeutic solutions.

Bhakti Bhargava, the Chief Financial Officer at ElevateBio, manages all financial operations and strategic fiscal planning. Bhargava oversees capital allocation, investor relations, and financial risk management, ensuring the company's robust financial health. This role is critical in supporting the expansion of ElevateBio's portfolio of cell and gene therapy companies, requiring astute financial foresight. The Chief Financial Officer drives the financial strategy that underpins partnerships with innovative scientists and inventors, facilitating the operationalization of groundbreaking therapies. By optimizing financial structures and securing necessary funding, Bhakti Bhargava directly contributes to the company's ability to bring life-changing treatments to market and achieve its ambitious growth objectives.

Kareem Reda, the Chief Operating Officer at ElevateBio, directs the operational execution across the company's portfolio of cell and gene therapy ventures. Reda oversees the scaling of operations and the efficient integration of new therapeutic platforms, ensuring seamless collaboration between scientific innovation and market delivery. This critical role involves optimizing the operational infrastructure that supports partnerships with leading scientists and inventors. The Chief Operating Officer drives process improvements and operational excellence, directly impacting the speed and effectiveness with which ElevateBio can develop and deploy advanced therapies. By managing day-to-day operations and ensuring resource optimization, Kareem Reda is instrumental in translating scientific breakthroughs into tangible patient benefits and achieving the company's strategic goals.

Michael Paglia, the Chief Technology Officer, Elevatebio Basecamp at ElevateBio, leads the technological strategy and infrastructure development for the company's core operational hub. Paglia architects the advanced technological systems essential for the creation and operation of cell and gene therapy companies, ensuring cutting-edge capabilities. This position involves overseeing the digital transformation and technological innovation that supports ElevateBio's partnerships with scientists and inventors. The Chief Technology Officer, Elevatebio Basecamp drives the implementation of robust data management, computational biology tools, and scalable IT solutions. By advancing the technological foundation, Michael Paglia directly enables the efficient development and manufacturing of novel therapies, reinforcing ElevateBio's commitment to pioneering advancements in biotechnology.